A detailed history of Greenwich Wealth Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Greenwich Wealth Management LLC holds 6,957 shares of GILD stock, worth $653,610. This represents 0.04% of its overall portfolio holdings.

Number of Shares
6,957
Previous 7,683 9.45%
Holding current value
$653,610
Previous $527,000 10.63%
% of portfolio
0.04%
Previous 0.04%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$66.59 - $83.99 $48,344 - $60,976
-726 Reduced 9.45%
6,957 $583,000
Q2 2024

Aug 09, 2024

BUY
$63.15 - $72.88 $18,881 - $21,791
299 Added 4.05%
7,683 $527,000
Q1 2024

May 13, 2024

BUY
$71.58 - $87.29 $25,339 - $30,900
354 Added 5.04%
7,384 $541,000
Q4 2023

Feb 01, 2024

SELL
$73.27 - $83.09 $7,620 - $8,641
-104 Reduced 1.46%
7,030 $570,000
Q3 2023

Nov 07, 2023

BUY
$73.94 - $80.67 $26,396 - $28,799
357 Added 5.27%
7,134 $535,000
Q2 2023

Jul 31, 2023

BUY
$76.01 - $86.7 $23,943 - $27,310
315 Added 4.87%
6,777 $522,000
Q1 2023

Apr 24, 2023

SELL
$77.31 - $88.08 $48,241 - $54,961
-624 Reduced 8.81%
6,462 $536,000
Q4 2022

Feb 06, 2023

SELL
$62.32 - $89.47 $20,565 - $29,525
-330 Reduced 4.45%
7,086 $608,000
Q3 2022

Nov 14, 2022

SELL
$59.54 - $68.01 $31,853 - $36,385
-535 Reduced 6.73%
7,416 $458,000
Q2 2022

Aug 08, 2022

SELL
$57.72 - $65.01 $1,212 - $1,365
-21 Reduced 0.26%
7,951 $491,000
Q1 2022

May 11, 2022

SELL
$57.92 - $72.58 $752 - $943
-13 Reduced 0.16%
7,972 $474,000
Q4 2021

Jan 28, 2022

BUY
$64.88 - $73.64 $113,799 - $129,164
1,754 Added 28.15%
7,985 $580,000
Q3 2021

Oct 19, 2021

BUY
$67.69 - $73.03 $59,702 - $64,412
882 Added 16.49%
6,231 $435,000
Q2 2021

Jul 27, 2021

SELL
$63.47 - $69.35 $38,018 - $41,540
-599 Reduced 10.07%
5,349 $368,000
Q1 2021

May 06, 2021

SELL
$60.0 - $68.46 $6,360 - $7,256
-106 Reduced 1.75%
5,948 $384,000
Q4 2020

Feb 12, 2021

SELL
$56.65 - $64.55 $5,438 - $6,196
-96 Reduced 1.56%
6,054 $353,000
Q3 2020

Oct 29, 2020

BUY
$62.1 - $78.08 $8,010 - $10,072
129 Added 2.14%
6,150 $389,000
Q2 2020

Aug 11, 2020

BUY
$72.34 - $84.0 $26,982 - $31,332
373 Added 6.6%
6,021 $463,000
Q1 2020

May 12, 2020

SELL
$62.63 - $80.22 $16,409 - $21,017
-262 Reduced 4.43%
5,648 $422,000
Q4 2019

Feb 10, 2020

SELL
$61.62 - $67.78 $3,265 - $3,592
-53 Reduced 0.89%
5,910 $384,000
Q3 2019

Nov 12, 2019

SELL
$62.51 - $69.0 $59,822 - $66,033
-957 Reduced 13.83%
5,963 $378,000
Q2 2019

Aug 13, 2019

BUY
$61.87 - $69.38 $16,271 - $18,246
263 Added 3.95%
6,920 $468,000
Q1 2019

May 14, 2019

BUY
$62.53 - $70.05 $10,567 - $11,838
169 Added 2.6%
6,657 $433,000
Q4 2018

Feb 11, 2019

SELL
$60.54 - $79.0 $8,959 - $11,692
-148 Reduced 2.23%
6,488 $406,000
Q3 2018

Nov 07, 2018

BUY
$71.28 - $78.92 $20,528 - $22,728
288 Added 4.54%
6,636 $512,000
Q2 2018

Jul 25, 2018

SELL
$64.88 - $75.68 $134,950 - $157,414
-2,080 Reduced 24.68%
6,348 $450,000
Q1 2018

May 02, 2018

BUY
$72.84 - $88.8 $14,786 - $18,026
203 Added 2.47%
8,428 $635,000
Q4 2017

Feb 07, 2018

SELL
$71.15 - $83.52 $21,629 - $25,390
-304 Reduced 3.56%
8,225 $589,000
Q3 2017

Nov 14, 2017

SELL
$72.11 - $85.47 $52,063 - $61,709
-722 Reduced 7.8%
8,529 $691,000
Q2 2017

Aug 14, 2017

BUY
N/A
9,251
9,251 $655,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $118B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Greenwich Wealth Management LLC Portfolio

Follow Greenwich Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenwich Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Greenwich Wealth Management LLC with notifications on news.